Source: Pulse2.0

Kymab: Why Sanofi Is Buying Kymab For Up To $1.45 Billion

Sanofi recently announced that it is going to buy Kymab. These are the details. The post Why Sanofi Is Buying Kymab For Up To $1.45 Billion appeared first on Pulse 2.0.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more